Latest Product Development News

OD6 Metals has recalibrated its Horseshoe fluorspar grades upward by nearly 13% following a re-assay program, confirming exceptional high-grade mineralisation near surface at its Quinn Project in Nevada.

3P Learning reports a statutory net profit of $9.9 million and a 26% rise in underlying EBITDA to $19.5 million for FY26, declaring a 3.52 cent dividend after more than a decade.

NZME delivered a notable turnaround in the first half of 2026, doubling operating profit and cutting net debt by $13.9 million, led by strong audio revenue and digital expansion despite a challenging economic backdrop.

Oakridge International Limited has reversed its fortunes with a 42% revenue increase to $3.45 million and a return to profitability in FY2026, driven by healthcare technology sales and strategic platform enhancements.

TALi Digital is acquiring Datasphere Analytics to access cutting-edge memristive in-memory computing technology, aiming to enhance its AI-driven education platform. The company is concurrently raising $3.3 million to fund this strategic move and ongoing operations.

QuickFee Limited swung to a A$39.3 million profit for FY26, propelled by the lucrative sale of its US Pay Now products, while trimming costs and declaring its first dividends.

Sparc Technologies launches a $2.5 million capital raise via a Share Purchase Plan and placement to fast-track commercial rollout of its graphene additive ecosparc® and support green hydrogen scale-up.

Skellerup Holdings delivered a tenth consecutive year of EBIT growth with a 14% rise to NZD 89.3 million and expanded its climate initiatives, reporting a 24% jump in net profit to NZD 67.7 million.

H2G Limited trims its half-year loss by a third while advancing sodium-ion battery production and securing a $4.5 million sales pipeline. Strategic partnerships and government certification efforts aim to boost market adoption.

SCX.ai Holdings Limited is set to raise $40 million through a fully underwritten IPO at $0.30 per share, aiming to scale its sovereign AI inferencing platform built on ASIC hardware within Australian data centres. The company targets the fast-growing AI IaaS market with a focus on secure, low-latency AI workloads.

Artrya Limited marked its first full year of US commercial operations with a $25.18 million loss, driven by regulatory clearances, customer contracts, and an $80 million capital raise.

ReNerve Ltd (ASX:RNV) reported an 80% year-on-year revenue increase in Q4 FY26, backed by expanding product lines and a $5 million funding facility. The company is advancing FDA approvals and growing its global distribution footprint, targeting a rapidly expanding $6.19 billion nerve repair biomaterials market.